Ebrahim Versi
Chief Executive Officer bei DMK PHARMACEUTICALS CORPORATION
Vermögen: 455 $ am 31.03.2024
Profil
Ebrahim Versi is the founder of Dignify Therapeutics LLC (founded in 2013) and DMK Pharmaceuticals Corp.
(Old) (founded in 2016).
He is currently the Chairman & Chief Executive Officer at DMK Pharmaceuticals Corp.
and holds positions as a Member at the Royal College of Obstetricians & Gynaecologists and President at Versi Group LLC.
Dr. Versi's former positions include Chief Executive Officer & Director at Vaneltix Pharma, Inc., Director-Urology & Health at Pfizer Inc. (held from 1999 to 2003), Chief Medical Officer at Mt.
Cook Pharma, Inc. (held from 2007 to 2009), Professor at Harvard University, Principal at The Brigham & Women's Hospital, Inc., Senior Vice President-Development at Plethora Solutions Plc (held from 2006 to 2007), Vice President-Medical Affairs at Yamanouchi Pharma America, Inc., and President at Veris Consulting, Inc. Dr. Versi's education includes undergraduate and doctorate degrees from the University of Oxford and a doctorate degree from the University of Cambridge.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.10.2023 | 8 745 ( 0,09% ) | 455 $ | 31.03.2024 |
Aktive Positionen von Ebrahim Versi
| Unternehmen | Position | Beginn |
|---|---|---|
| DMK PHARMACEUTICALS CORPORATION | Chief Executive Officer | 25.05.2023 |
| Royal College of Obstetricians & Gynaecologists | Corporate Officer/Principal | - |
| Versi Group LLC | President | - |
Ehemalige bekannte Positionen von Ebrahim Versi
| Unternehmen | Position | Ende |
|---|---|---|
Mt. Cook Pharma, Inc.
 Mt. Cook Pharma, Inc. Pharmaceuticals: MajorHealth Technology Mt. Cook Pharma, Inc. provides treatment for urological diseases. It offers services to overactive bladder, lower urinary symptoms, and interstitial cystitis diseases. The company was headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | - |
| Plethora Solutions Plc | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
DMK Pharmaceuticals Corp. (Old)
 DMK Pharmaceuticals Corp. (Old) BiotechnologyHealth Technology DMK Pharmaceuticals Corp. (Old) was an American commercial stage neuro-biotech company that focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders. The company's approved products included Zimhi® (naloxone) injection for the treatment of opioid overdose and Symjepi® (epinephrine) injection for use in the emergency treatment of acute allergic reactions, including anaphylaxis. The company was founded by Neil M. Frazer and Ebrahim Versi. DMK Pharmaceuticals Corp. was acquired by DMK Pharmaceuticals Corp. on May 25, 2023 for $27 million. | Chief Executive Officer | - |
Dignify Therapeutics LLC
 Dignify Therapeutics LLC Pharmaceuticals: MajorHealth Technology Dignify Therapeutics LLC offers pharmaceutical services. It provides bladder and bowel for people who have spinal cord injury. The company was founded by Edward C. Burgard, Karl B. Thor, Lesley Marson, Venkateswarlu Karicheti, Daniel J. Ricca, Florenta Aura Kullmann, Ebrahim Versi, Benny L. Ward, Tatyana Touzova and Mary Katofiasc and is headquartered in Research Triangle Park, NC. | Founder | - |
Ausbildung von Ebrahim Versi
| University of Oxford | Doctorate Degree |
| University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Mt. Cook Pharma, Inc.
Mt. Cook Pharma, Inc. Pharmaceuticals: MajorHealth Technology Mt. Cook Pharma, Inc. provides treatment for urological diseases. It offers services to overactive bladder, lower urinary symptoms, and interstitial cystitis diseases. The company was headquartered in Princeton, NJ. | Health Technology |
Dignify Therapeutics LLC
Dignify Therapeutics LLC Pharmaceuticals: MajorHealth Technology Dignify Therapeutics LLC offers pharmaceutical services. It provides bladder and bowel for people who have spinal cord injury. The company was founded by Edward C. Burgard, Karl B. Thor, Lesley Marson, Venkateswarlu Karicheti, Daniel J. Ricca, Florenta Aura Kullmann, Ebrahim Versi, Benny L. Ward, Tatyana Touzova and Mary Katofiasc and is headquartered in Research Triangle Park, NC. | Health Technology |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Health Services |
Vaneltix Pharma, Inc.
 Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Health Technology |
| Plethora Solutions Plc | |
| Yamanouchi Pharma America, Inc. | |
| DMK Pharmaceuticals Corp. | |
Veris Consulting, Inc.
 Veris Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Veris Consulting, Inc. provides forensic accounting services. The firm offers consulting services in forensic accounting, litigation support, accounting consulting and business research. The company was founded by Larry R. Johnson in 2000 and is headquartered in Reston, VA. | Commercial Services |
| Versi Group LLC | |
DMK Pharmaceuticals Corp. (Old)
DMK Pharmaceuticals Corp. (Old) BiotechnologyHealth Technology DMK Pharmaceuticals Corp. (Old) was an American commercial stage neuro-biotech company that focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders. The company's approved products included Zimhi® (naloxone) injection for the treatment of opioid overdose and Symjepi® (epinephrine) injection for use in the emergency treatment of acute allergic reactions, including anaphylaxis. The company was founded by Neil M. Frazer and Ebrahim Versi. DMK Pharmaceuticals Corp. was acquired by DMK Pharmaceuticals Corp. on May 25, 2023 for $27 million. | Health Technology |
